Self-expandable Metallic Stent Insertion for Nonresectable Esophageal Cancer Patients.

2001 ◽  
Vol 52 (2) ◽  
pp. 75-81
Author(s):  
Hideo Shimada ◽  
Osamu Chino ◽  
Takayuki Nishi ◽  
Hikaru Tanaka ◽  
Yoshifumi Kise ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
Stent Insertion ◽  
Metallic Stent ◽  
Expandable Metallic Stent

Comparative study of self-expandable metallic stent and bypass surgery for inoperable esophageal cancer

2001 ◽  
Vol 14 (3-4) ◽  
pp. 208-211 ◽  
Author(s):  
T. Aoki ◽  
Y. Osaka ◽  
Y. Takagi ◽  
R. Okada ◽  
M. Shinohara ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Comparative Study ◽  
Bypass Surgery ◽  
Metallic Stent ◽  
Expandable Metallic Stent

scholarly journals Assesment of placement of the esophageal self-expandable metallic stent in esophageal cancer in patients with or without citorreduction therapy

2007 ◽  
Vol 20 (3) ◽  
pp. 154-160
Author(s):  
Gilson Kamiyama ◽  
Paulo Sakai ◽  
Eduardo Guimarães H. de Moura ◽  
Shinichi Ishioka ◽  
Ivan Cecconello ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Survival Time ◽  
Stent Placement ◽  
Gastrointestinal Endoscopy ◽  
Thoracic Esophagus ◽  
Metallic Stent ◽  
Advanced Esophageal Cancer ◽  
Expandable Metallic Stent ◽  
Stent Treatment ◽  
Time Average

BACKGROUND: Placement of self-expanding metallic esophageal stent in patients with advanced esophageal cancer offers excellent palliation of dysphagia and tracheo-esophageal fistulas. However, the safety of stent in patients undergoing radio and/or chemotherapy is controversial, in terms of the greater risk of complications in cases where these two treatments are used in conjunction. AIM: To assess the use of stent in patients with advanced cancer of the mid-thoracic esophagus, by comparing patients undergoing cytoreductive therapy with patients who have not undergone this treatment, in relation to improvement in the dysphagia, rate of complications, period of effectiveness and survival time. METHODS: Fifty seven patients were evaluated retrospectively (16 women and 41 men, with an average age 62 years) with advanced squamous cell carcinoma of the mid-thoracic esophagus who underwent placement of the Ultraflex™ self-expandable metallic coated stent, at the Gastrointestinal Endoscopy Unit of São Paulo University Medical School between October 1988 and October 2004. Out of the 57 patients, 24 patients received adjuvant cytoreductive therapy, and 33 patients were only treated with the stent placement. RESULTS: After stent placement, there was improvement in dysphagia in both groups; there were no differences in the rate of complications, such as migration, pain, fistula, obstruction and compression of the airways; the period of effectiveness was significantly higher in the group submitted to cytoreductive therapy (average 123 days compared to 63 days), as was the survival time (average of 210 days, compared with 120 days). CONCLUSIONS: Improvement in dysphagia was statistically significant in both groups, irrespective of whether the patient had undergone adjuvant cytoreductive therapy; there were no differences in the rate of complications between the two groups and both the period of effectiveness of the stent treatment and the survival time were higher in the group with adjuvant cytoreductive therapy.

scholarly journals Three Cases of Palliative Therapy for Unresectable Esophageal Cancer with Silicone Coated Self-expandable Metallic Stent.

1994 ◽  
Vol 27 (12) ◽  
pp. 2564-2568
Author(s):  
Akira Hayashibe ◽  
Hajime Tanaka ◽  
Hideki Kitoh ◽  
Kazutsugu Sakamoto ◽  
Eiji Taruya ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Palliative Therapy ◽  
Metallic Stent ◽  
Expandable Metallic Stent

scholarly journals Serious Complications after Self-expandable Metallic Stent Insertion in a Patient with Malignant Lymphoma

2015 ◽  
Vol 78 (1) ◽  
pp. 31 ◽  
Author(s):  
Sung Bae Cho ◽  
Seon Ah Cha ◽  
Joon Young Choi ◽  
Jong Min Lee ◽  
Hyeon Hui Kang ◽  
...  
Keyword(s):  
Malignant Lymphoma ◽  
Stent Insertion ◽  
Metallic Stent ◽  
Expandable Metallic Stent

scholarly journals Endoscopic biliary self-expandable metallic stent in malignant biliary obstruction with or without sphincterotomy: systematic review and meta-analysis

2019 ◽  
Vol 07 (01) ◽  
pp. E26-E35 ◽  
Author(s):  
Benedetto Mangiavillano ◽  
Amedeo Montale ◽  
Leonardo Frazzoni ◽  
Mario Bianchetti ◽  
Amrita Sethi ◽  
...  
Keyword(s):  
Adverse Events ◽  
Success Rate ◽  
Meta Analysis ◽  
Stent Insertion ◽  
Metallic Stent ◽  
Success Rates ◽  
Technical Success ◽  
Technical Success Rate ◽  
Expandable Metallic Stent ◽  
Increased Risk

Abstract Background and aim To assess the rate of adverse events and the technical success rate of biliary stenting with or without EBS.  Methods A literature search up to February 2017 was performed. Studies assessing adverse events (AEs) and technical success rates of stenting with or without EBS were considered. Results Seven studies (870 patients; 12 treatment arms) were included. Early AEs, i. e. those occurring within 30 days, were significantly lower in no-EBS vs. EBS-group (11 % vs. 20.1 %; OR: 0.36, 95 %CI: 0.13 – 1.00). Rates of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis were not significantly different in the two groups (no-EBS vs. EBS: 6.1 % vs 5 %; OR: 1.33, 95 %CI: 0.68 – 2.59). The rate of bleeding was significantly lower in patients without EBS (no-EBS vs EBS: 0 % vs 5 %; OR: 0.12, 95 % CI: 0.03 – 0.45). Rates of cholangitis were significantly lower in patients without EBS (no-EBS vs. EBS: 3.3 % vs. 7.4 %; OR: 0.38, 95 %CI: 0.17 – 0.83). Both late AEs and mortality rates did not significantly differ between no-EBS and EBS patients (19.9 % vs. 18.9 %; OR: 0.93, 95 %CI: 0.56 – 1.53, and 2.5 % vs. 2.9 %; OR: 1.18, 95 %CI: 0.22 – 6.29, respectively). The technical success rate for stent insertion also did not differ (98 % vs. 97.6 %; OR: 1.05, 95 %CI: 0.42 – 2.63). Conclusion EBS seems to be associated, in the first 30 days after the procedure, with an increased risk of cholangitis and bleeding. No difference was observed in the rate of post-ERCP pancreatitis.

Su1510 Long-Term Complications of Self-Expandable Metallic Stent in Patients With Advanced Esophageal Cancer

2014 ◽  
Vol 79 (5) ◽  
pp. AB303
Author(s):  
Bruno C. Martins ◽  
Clarissa R. Villar ◽  
Maria Sylvia I. Ribeiro ◽  
Marcelo S. Lima ◽  
Flavio R. Takeda ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Metallic Stent ◽  
Advanced Esophageal Cancer ◽  
Expandable Metallic Stent

scholarly journals Successful Stent-in-stent Insertion of an Expandable Metallic Stent Covered with Polyuretane Placed to Obliterate a Large Bronchial Fistula after Chemoradiotherapy for Inoperable Lung Cancer.

Haigan ◽  
1999 ◽  
Vol 39 (6) ◽  
pp. 877-880
Author(s):  
Hiroya Minami ◽  
Noriaki Tsubota ◽  
Yoshifumi Miyamoto ◽  
Masahiro Yoshimura ◽  
Kayoko Obayashi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Stent Insertion ◽  
Metallic Stent ◽  
Bronchial Fistula ◽  
Expandable Metallic Stent

scholarly journals Aortic Pseudoaneurysm Formation Following Concurrent Chemoradiotherapy And Metallic Stent Insertion in a Patient With Esophageal Cancer

Medicine ◽  
2015 ◽  
Vol 94 (20) ◽  
pp. e862 ◽  
Author(s):  
Pei-Yu Hou ◽  
Chung-Jen Teng ◽  
Chen-Shuan Chung ◽  
Chao-Yu Liu ◽  
Chun-Chieh Huang ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Concurrent Chemoradiotherapy ◽  
Stent Insertion ◽  
Metallic Stent ◽  
Aortic Pseudoaneurysm ◽  
Pseudoaneurysm Formation
Sign in / Sign up

Export Citation Format

Share Document